Demo

4308 Articles Matching "treatment"

Researchers Uncover Potential New Drug Targets In The Fight Against HIV

Aug 10, 2018 , NewsLine - Healthcare Professionals
Johns Hopkins scientists report they have identified two potential new drug targets for the treatment of HIV. The finding is from results of a small, preliminary study of 19 people infected with both HIV—the virus that causes AIDS—and the hepatitis C virus. The study revealed that two genes—CMPK2 an......
Read more

A Deeper Look At Severe Asthma Yields NET Results

Aug 10, 2018 , NewsLine - Healthcare Professionals
Of the more than 24 million people in the U.S. who have asthma, 10% have severe asthma - a form of the disease that does not respond to treatment. The immunological mechanisms underlying severe asthma and asthmatic lung inflammation are not well understood. A new study by investigators from Brigham ......
Read more

Families, Health Care Teams Turn To New Approaches To Help People Caught Up In Opioid Epidemic

Aug 09, 2018 , Kaiser Health News
Rather than immediately sending newborns dependent on opioids to foster care, Kansas City health officials are working to keep the families together. Other new ideas include not letting a family member hit "rock bottom" and using more medication-assisted treatments to keep people...
Read more

Leo Pharma to acquire Bayer’s dermatology unit

Aug 09, 2018 , Drug Store News - Retail
Leo Pharma's acquisition of Bayer's branded topical prescription treatments include drugs for acne, fungal skin infections and rosacea, as well a range of topical steroids. Read More...
Read more

RegenXBio Gene Therapy Shows Early Promise For Eye Disease; Cholesterol Treatment Results Mixed

Aug 09, 2018 , Forbes
A gene therapy being developed by RegenX Bio of Rockville, MD, showed early promise against wet macular degeneration, a leading cause of...
Read more
Demo

Preventing Hair Loss During Chemotherapy Is Now Possible, But Insurance Coverage Is Inconsistent

Aug 09, 2018 , Forbes
Preventing hair loss during chemotherapy treatment is now possible, but insurance companies are not currently frequently covering the treatment...
Read more

FDA continues push for new opioid use disorder treatments

Aug 09, 2018 , Drug Store News - Retail
The FDA has issued a new draft guidance to promote more widespread development, access, and adoption of medication-assisted treatment products for opioid use disorder. Read More...
Read more

U.S. joins lawsuits against Indivior, Reckitt over drug Suboxone

Aug 09, 2018 , Reuters
The U.S. Justice Department has joined several whistleblower lawsuits against Indivior Plc and Reckitt Benckiser Group PLC, alleging that the drugmakers improperly marketed the opioid addiction treatment Suboxone....
Read more

FDA approves new indication, vial presentation for Teva’s Granix

Aug 09, 2018 , Drug Store News - Retail
Teva’s Neupogen biosimilar Granix has been granted FDA approval for updated indication and vial presentation, which it said would provide pediatric patients with new treatment options. Read More...
Read more

Which Drugs Work Best for ADHD? Large Study Zeroes in on Two

Aug 09, 2018 , WebMD
The researchers compared seven ADHD drugs -- amphetamines (including lisdexamfetamine), atomoxetine, bupropion, clonidine, guanfacine, methylphenidate and modafinil -- and a placebo over 12 weeks of...
Read more

CVS MinuteClinic Launches Video Doctor Visits Via Teladoc Platform

Aug 08, 2018 , Forbes
CVS Health’s MinuteClinic is launching a new “virtual health care offering” to allow patients round-the-clock treatment for minor illnesses, injuries and conditions from their mobile...
Read more
Banner Health Children

Eucrisa vs. Elidel

Aug 08, 2018 , RxList
Eucrisa (crisaborole) ointment and Elidel (pimecrolimus) cream are indicated for topical treatment of mild to moderate atopic dermatitis (eczema) in patients 2 years of age and older.Eucrisa and Elidel belong to different drug classes. Eucrisa is a phosphodiesterase 4 inhibitor and Elidel is a calcineurin...
Read more

Eucrisa vs. Dupixent

Aug 08, 2018 , RxList
Eucrisa (crisaborole) ointment and Dupixent (dupilumab) injection are indicated for topical treatment of atopic dermatitis (eczema) in patients 2 years of age and older....
Read more

FDA Takes Steps To Encourage Development Of Medication That Can Be Used To Aid Addiction Treatment

Aug 08, 2018 , Kaiser Health News
Currently, just three drugs exist to treat opioid use disorder: buprenorphine, methadone, and naltrexone. Adherence to the drugs is typically low, and addiction treatment experts have long said medication assisted treatment is vastly...
Read more

Eucrisa vs. Temovate

Aug 08, 2018 , RxList
Eucrisa (crisaborole) and Temovate (clobetasol propionate) are indicated for topical treatment of atopic dermatitis (eczema). Temovate is also used to treat the inflammation and itching caused by a number of skin conditions such as allergic reactions and psoriasis....
Read more

FDA declines to approve Pain Therapeutics' opioid drug, shares plunge

Aug 07, 2018 , Reuters
The U.S. Food and Drug Administration declined to approve Pain Therapeutics Inc's abuse-deterrent opioid treatment Remoxy for the fourth time, sending the company's shares down 35 percent to a record low....
Read more

Libyan cancer clinic relies on donors to treat patients

Aug 07, 2018 , Reuters
One of Libya's few cancer clinics is relying on donors to keep its doors open for patients who often travel hundreds of kilometers (miles) for life-saving treatment....
Read more

FDA gives drugmakers new ways to prove opioid disorder treatments work

Aug 07, 2018 , Modern Healthcare Breaking News
The FDA has noticeably shifted its approach to drug approval, releasing new recommendations that give drug developers a wider array of outcome measures to prove the efficacy of new medication-assisted treatments for opioid use...
Read more

Better Prevention of Tick-borne Diseases Needed

Aug 07, 2018 , eMedicine Health
Better Prevention and Treatment of Tick-borne Diseases...
Read more

Better Prevention and Treatment of Tick-borne Diseases Needed

Aug 07, 2018 , RxList
The incidence of tick-borne disease in the United States is increasing at an alarming rate, officials from the National Institute of Allergy and Infectious Diseases say. They call on public health and biomedical researchers to double down on efforts to better understand the pathogenesis of tick-borne illnesses and to develop improved strategies for prevention and...
Read more